Evicenter
P&T meetings

SL1009 (sodium dichloroacetate)

Pyruvate dehydrogenase complex deficiency

Manufacturer
Saol Therapeutics
Regulatory submission
NDA resubmitted June 2026
Launch
Not announced
Last updated
78 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Limitations of current therapies

5 evidence topics · 6 sources

Summary

Ketogenic dietary treatment must be individualized because tolerance varies. A clinical-practice review identified 40 studies describing 129 participants, predominantly case reports or case series. A separate treatment scoping review included seven preclinical and ten human studies and concluded that most interventions had not been rigorously investigated. These evidence designs limit the certainty of comparative treatment effects.